Patents
Patents for C07D 285 - Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups (9,964)
05/2011
05/03/2011US7935685 Process for preparation of inclusion compounds between a non-steroidal anti-inflammatory drug and betacyclodextrin by microwave treatment
05/03/2011CA2528920C Cyclo(hetero)alkenyl compounds useful for treating pain
04/2011
04/28/2011WO2011049531A1 N-type materials and organic electronic devices
04/28/2011US20110098274 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors
04/26/2011CA2446461C Substituted cyclohexane-1,4-diamine derivatives
04/21/2011WO2011046954A1 Hematopoietic growth factor mimetic small molecule compounds and their uses
04/21/2011US20110092553 Substituted Azole Derivatives, Compositions, and Methods of Use
04/20/2011EP2310361A1 Fungicidal n-(2-phenoxyethyl)carboxamide derivatives and their aza, thia and sila analogues
04/20/2011EP1585739B1 Substituted arylcyclopropylacetamides as glucokinase activators
04/20/2011CN102026990A Novel inhibitors of hepatitis c virus replication
04/20/2011CN102026970A Biaryl pde4 inhibitors for treating pulmonary and cardiovascular disorders
04/14/2011WO2011042525A1 Rubber composition comprising a thiadiazole
04/14/2011WO2011042523A1 Thiadiazole which can be used as a vulcanization accelerator and method for obtaining same
04/14/2011US20110086893 Oxa- and thiadiazoles and their use as metalloproteinase inhibitors
04/14/2011CA2774579A1 Iminothiadiazine dioxide compounds as bace inhibitors, compositions, and their use
04/13/2011EP2307391A2 Thiadiazolyloxyphenylamidines and use thereof as fungicides
04/13/2011EP2307390A2 Thiadiazolyloxyphenylamidines and use thereof as fungicides
04/13/2011EP2307387A1 Novel heterocyclyl compounds for treatment of cardiovascular disease
04/13/2011EP2307017A1 Compounds which can be used for the treatment of cancers
04/13/2011CN1894199B Halogenated bisdiarylaminopolycyclic aromatic compounds and polymers thereof
04/12/2011CA2471099C .alpha.-(n-sulphonamido)acetamide derivatives as .beta.-amyloid inhibitors
04/12/2011CA2419768C Amino acid-derived, 7-membered cyclic sulfamides and methods of synthesizing the same
04/12/2011CA2387107C Derivatives of dicarboxylic acid having pharmaceutical properties
04/07/2011WO2011039403A1 Substituted 5-imino-1,2,4-thiadiazoles that can be used to treat neurodegenerative diseases
04/07/2011CA2780695A1 Substituted 5-imino-1,2,4-thiadiazoles that can be used to treat neurodegenerative diseases
04/06/2011EP2305660A1 New thiadiazole derivatives
04/06/2011EP2305648A1 Amide derivatives useful as glucokinase activators
04/06/2011EP1219607B1 Integrase inhibitors containing aromatic heterocycle derivatives
04/06/2011CN102007103A Substituted sulfonic acid amide compounds
04/06/2011CN101068796B Compounds, compositions and thin films
04/05/2011US7919514 Protein kinase B inhibitors; anticarcinogenic, antiinflammatory and antiproliferative agents; metabolic disorders; 3-(3-fluoro-phenyl)-N-[5-(3-methyl-1H-indazol-5-yl)-[1,3,4]thiadiazol-2-yl]-propane-1,2-diamine and derivatives
04/05/2011US7919496 5-[4-(2-Trifluoromethylbenzoyl)piperazin-1-yl]-[1,3,4]thiadiazole-2-carboxylic acid ethyl ester; metabolic disorders type II diabetes, impaired glucose tolerance, insulin resistance, obesity, fatty liver, non-alcoholic steatohepatitis, dyslipidemia and metabolic syndrome; cardiovascular disorders
04/05/2011CA2408747C Heterocyclic inhibitors of glycogen synthase kinase gsk-3
03/2011
03/31/2011WO2011035900A1 New thiadiazole derivatives
03/31/2011US20110077409 Process for the preparation of certain substituted sulfilimines
03/31/2011US20110077234 Urea Glucokinase Activators
03/30/2011EP1742927B1 Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications threreof
03/30/2011CN1946398B Thiadiazolidinones as gsk-3 inhibitors
03/29/2011US7915402 Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the C-ring
03/29/2011US7915249 serotonin 5-HT2A, 5-HT2C and dopamin D2 receptors antagonist, and norepinephrine reuptake inhibitor; antidepressant, anxiolytic agent; psychosis, schizophrenia, bipolar and sexual disorders, obesity
03/29/2011US7914817 Treatment of inflammatory bowel disease
03/23/2011EP2298779A1 Sulfonamide derivatives as glycokinase activators useful in the treatment of type 2 diabetes
03/23/2011EP2200991B1 Antibacterial agents
03/23/2011CN101987837A Preparation method of 1,2,4-thiadiazole oximido acetic acid compound
03/22/2011US7910745 Organic compound and method for producing radioactive halogen-labeled organic compound using the same
03/22/2011US7910612 4-oxy-N-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, pharmaceutical compositions and methods for their therapeutic use
03/17/2011US20110065918 New phenylalanine derivatives
03/17/2011US20110065710 Insecticidal N-(Heteroarylalkyl)Alkanediamine Derivatives
03/16/2011EP2295402A2 Antibacterial agents
03/15/2011US7906724 N-type conjugated materials based on 2-vinyl-4,5-dicyanoimidazoles and their use in organic photovoltaics
03/15/2011US7906653 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
03/15/2011US7906235 Pentacyclic anion salts or tetrazapentalene derivatives and their uses as ionic conducting materials
03/10/2011WO2011027888A1 Diamide-phenyl derivative and pharmaceutically acceptable salt thereof
03/10/2011US20110060019 Heteroaryl-ureas and their use as glucokinase activators
03/09/2011EP2292608A1 Intermediates for the preparation of substituted Aminosalicylic acid amides with fungicidal activity
03/09/2011EP2291351A1 Alpha-mercapto-amides
03/08/2011US7902372 Therapy for obesity; using a secondary amino compound
03/08/2011US7902241 Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease
03/08/2011US7902234 Thiadiazoline derivative
03/08/2011US7902203 Polymerase inhibitors; viricides; hepatitis c virus; immunology moderator; antiinflammatory agents; cirrhosis; liver disorders
03/08/2011US7902186 Substituted 5-phenyl-3,6-dihydro-2-oxo-6H-1,3,4-thiadiazines
03/03/2011WO2011023864A1 Pseudodipeptides as mmp inhibitors
03/03/2011WO2011004162A3 1, 2, 4-thiazolidin-3-one derivatives and their use in the treatment of cancer
03/02/2011EP2289510A1 Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-coa desaturase enzymes
03/02/2011EP1578715B1 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
03/01/2011US7897628 {2-[3-(4-Methyl-2-[2-methypropoxy]phenyl)-ureido]-thiazol-4-yl}-acetic acid ethyl ester; glucokinase inhibitor; antidiabetic, hypoglycemic agent; activators of glucokinase
02/2011
02/24/2011WO2011021696A1 Palladium ion adsorbent and method for separating and recovering palladium using same
02/24/2011US20110046387 5-aryl-4-(5-substituted 2,4-dihydroxyphenyl)-1,2,3-thiadiazoles as inhibitors of hsp90 chaperone and the intermediates for production thereof
02/24/2011US20110046182 Efficient aspirin prodrugs
02/24/2011US20110046147 17beta-hydroxysteroid dehydrogenase type 1 inhibitors for the treatment of hormone-related diseases
02/24/2011US20110046129 2-Phenylethylamino Derivatives as Calcium and/or Sodium Channel Modulators
02/24/2011US20110044918 Novel sulfamide derivatives and cosmetic use thereof
02/23/2011CN101981029A Benzophenone thiazole derivatives useful for inhibiting formation of microtubule and method for producing the same
02/23/2011CN101979394A A method to inhibit ethylene responses in plants
02/22/2011US7894769 Wireless microphone communication system
02/22/2011CA2484159C Heteroaryl substituted spirocyclic sulfamides for inhibition of gamma secretase
02/17/2011US20110040094 1,3,4-trisubstituted benzenes
02/17/2011US20110039819 Substituted phenoxybenzamides
02/17/2011US20110039815 Macrocyclic metal complexes for their use as anticancer agents
02/17/2011US20110039802 Npy y5 antagonist
02/17/2011CA2770896A1 Cathepsin c inhibitors
02/16/2011EP2283002A2 Novel inhibitors of hepatitis c virus replication
02/16/2011EP1379498B1 Sulphones which modulate the action of gamma secretase
02/16/2011CN1846456B Communication system for wireless microphone
02/16/2011CN101973962A Preparation method of buprofezin
02/16/2011CN101973961A Preparation method for bentazone
02/16/2011CN101973960A Improved method for preparing benzo[d][1,2,3] thiadiazole-7-formic acid trifluoroacetate
02/16/2011CN101973959A 4-methyl-1,2,3-thiadiazole-5-formyl urea compounds and preparation method and application thereof
02/16/2011CN101585819B Preparation method for 1,2,3-thiadiazole thioacetanilides derivatives
02/15/2011CA2480562C 5-substituted 1,1-dioxo-1,2,5-thiazolidine-3-one derivatives as ptpase 1b inhibitors
02/10/2011US20110034524 Hemi-fumarate salt of a 1,3,4-thiadiazolyl derivative as modulator of the sphingosine 1-phosphate receptor
02/10/2011US20110034432 Benzamide derivatives and their use as glucokinase activating agents
02/09/2011CN101970414A 1 ibeta-hydroxysteroid dehydrogenase inhibitors
02/09/2011CN101570522B Synthetic method suitable for industrial production of active ester
02/09/2011CN101205217B Compound, composite nano particle, grease and production methods thereof
02/08/2011US7884103 such as N-(4-Chloro-phenyl)-2-methyl-2-phenylmethanesulfonylamino-3-(4-[1,2,4]triazol-1-yl-phenoxy)-propionamide, used for controlling or preventing the infestation of plants by phytopathogenic microorganisms, especially fungi
02/03/2011US20110028656 Band gap control in conjugated oligomers and polymers via Lewis acids
02/02/2011EP1288205B1 Novel phenylalanine derivatives
02/02/2011CN101962371A Method for preparing ceftobiprole side chain acid and key intermediate thereof
02/01/2011US7879529 An alkaline-soluble, water-insoluble acrylic copolymer, a solvent and a fluorocompound to adjust the refractive index of the liquid of the immersion lithography process; antireflectivity; 1,3-tetraoxo,4,5-tetrafluoro-1,3,2-tetrahydrodithiazole
1 ... 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 ... 100